Using machine learning to detect Alzheimer's disease in veterans

Combining Machine Learning Methods and Scalable In Vivo Biomarkers for the Early and Accurate Detection of Alzheimer's Disease in Veterans

['FUNDING_OTHER'] · VA BOSTON HEALTH CARE SYSTEM · NIH-10918753

This study is working on a new, easy way to help veterans find out if they have Alzheimer's disease early on, using smart technology and simple tests, so they can get the right care before their memory starts to fade.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorVA BOSTON HEALTH CARE SYSTEM (nih funded)
Locations1 site (BOSTON, UNITED STATES)
Trial IDNIH-10918753 on ClinicalTrials.gov

What this research studies

This research focuses on improving the early detection of Alzheimer's disease (AD) in veterans by utilizing machine learning techniques combined with easily accessible in vivo biomarkers. The goal is to create a cost-effective and convenient tool that can identify AD pathology before significant cognitive decline occurs. By analyzing data from routine clinical neuropsychological tests and digital assessments, the project aims to enhance diagnostic accuracy and provide veterans with timely access to necessary treatments and services. The study will leverage existing data from veterans who have undergone advanced imaging to develop predictive models.

Who could benefit from this research

Good fit: Ideal candidates for this research are veterans who are experiencing cognitive changes or are at risk for Alzheimer's disease.

Not a fit: Patients who are not veterans or those who do not exhibit any cognitive symptoms may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of Alzheimer's disease in veterans, allowing for timely interventions and improved patient outcomes.

How similar studies have performed: While machine learning approaches have shown promise in other populations, this specific application within a veteran cohort is novel and has not been extensively tested.

Where this research is happening

BOSTON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia, Alzheimer disease detection

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.